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Abstract 
A growing number of studies indicate that mRNAs and long ncRNAs can affect protein 
populations by assembling dynamic ribonucleoprotein (RNP) granules. These phase-
separated molecular ‘sponges’, stabilized by quinary (transient and weak) interactions, 
control proteins involved in numerous biological functions. Retroviruses such as HIV-1 
form by self-assembly when their genomic RNA (gRNA) traps Gag and GagPol polyprotein 
precursors. Infectivity requires extracellular budding of the particle followed by 
maturation, an ordered processing of ~2400 Gag and ~120 GagPol by viral protease (PR). 
This leads to a condensed gRNA-NCp7 nucleocapsid and a CAp24-self-assembled capsid 
surrounding the RNP. The choreography by which all of these components dynamically 
interact during virus maturation is one of the missing milestones to fully depict the HIV life 
cycle. Here, we describe how HIV-1 has evolved a dynamic RNP granule with successive 
weak-strong-moderate quinary NC-gRNA networks during the sequential processing of the 
GagNC domain. We also reveal two palindromic RNA-binding triads on NC, KxxFxxQ and 
QxxFxxK, that provide quinary NC-gRNA interactions. Consequently, the nucleocapsid 
complex appears properly aggregated for capsid reassembly and reverse transcription, 
mandatory processes for viral infectivity. We show that PR is sequestered within this RNP 
and drives its maturation/condensation within minutes, this process being most effective at 
the end of budding. We anticipate such findings will stimulate further investigations of 
quinary interactions and emergent mechanisms in crowded environments throughout the 
wide and growing array of RNP granules. 
 
Introduction 
In response to cellular demands and physiological stresses1, eukaryotes have evolved 
mechanisms that sequester mRNAs and associated RNA-binding proteins into membrane-less 
organelles called RNA granules. Such self-assemblies form gel phases in the cell cytoplasm, 
which exhibit adaptable dynamic architectures depending on their composition and biological 
functionality2. The concept of biological glue has been suggested previously, such as in a crowded 
environment, the sum of many weak, termed quinary interactions, can promote the assembly of 
highly stable, but dynamic and transient multi-macromolecular complexes without any 
requirement for membrane compartmentalization3,4.  
Even though an HIV-1 particle is derived from the self-assembled P55Gag shell and is 
ultimately enveloped by a lipid membrane, the concept of quinary interactions is clearly 
applicable in describing its dynamic assembly at the mesoscopic scale – since it forms a confined 
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RNP gel phase in a highly crowded space, within a limited time frame and in a cooperative 
manner. P55Gag is composed from N- to C-termini of matrix (MAp17), capsid (CAp24), spacer 
peptide SP1, nucleocapsid (NC), spacer peptide SP2 and p6 protein. Key players here consist of 
NC protein intermediates with their variable nucleic acid (NA) binding properties that are 
dependent upon their processing state5-8. Tethered within the virion by approximately 2400 
GagNC domains, the two single strands of 9.2 kb-long gRNA specifically scaffold P55Gag self-
assembly. Subsequently, the HIV-1 RNP complex engages a granular condensation during the 
sequential proteolysis of the P55Gag RNA-binding domain into the mature nucleocapsid protein 
(NCp7) by the viral protease (PR)7,9,10. PR is derived by autoprocessing of a smaller number of 
GagPol within the P55Gag assembly that additionally contain reverse transcriptase (RT) and 
integrase (IN). Approximately 60 PR homodimers are potentially available to catalyze 
maturation, which principally requires 12000 cleavage events. Cleavage of GagNC by PR 
generates first NCp15 (NCp7-SP2-p6) bound to, and forming with the gRNA an RNP 
intermediate that physically detaches from the remaining outer MA-CA-SP1 shell. The second 
cleavage between SP2 and p6 releases NCp9 (NCp7-SP2) (Fig. 1a, Fig. 6b). Single-stranded 
nucleic acids (ssNA) stimulate both cleavage events in vitro6,11,12. The third cleavage produces 
the mature 55 amino acids (aa)-long NCp7 and SP2. Within the virus, NCp15 seems to condense 
gRNA less well than NCp9 and NCp713. Yet NCp9 does not appear as functional as NCp714. 
NCp15 and NCp9 are short-lived species not detected during typical virus production8. Why such 
intermediates are maintained along the HIV-1 maturation process remains unclear.  
HIV-1 PR is an aspartyl-protease, enzymatically active only as a homodimer. 
Recombinant PR is stabilized in vitro by high ionic strength (>1 M NaCl) and catalysis is strongly 
activated under acidic conditions (pH 5.0 or even lower). Lower salt (0.1M NaCl) and increasing 
the pH to 6.0 limits the acidic catalysis and shifts the equilibrium towards the monomer15. At 
quasi-neutral pH, in low salts and an excess of PR, the in vitro cleavage of Gag follows the 
sequential mechanism described above leading to NCp7 and the condensed RNP16. RNA or 
ssDNA promote NCp15 cleavage in vitro6,17, while recent reports have shown that direct RNA-
PR contacts enhance the enzyme activity12. Consequently, PR appears to engage in an intricate 
partnership with NC and gRNA during viral maturation that remains incompletely understood. 
HIV-1 NCp7 contains a small globular domain formed with two zinc fingers (ZFs) that generate 
a hydrophobic pocket with two aromatic residues (Phe16 and Trp37). This platform stacks with 
unpaired nucleotides, preferentially guanosines exposed in RNA or ssDNA secondary structures, 
while basic residues stabilize the complex through electrostatic interactions with the NA 
backbone. With particular stem-loops in gRNA or DNA, this results in the formation of specific 
complexes18,19. NCp7 is also a highly mobile and flexible polycationic condensing agent; like 
polyamines, transient protein:NA electrostatic contacts neutralize phosphate backbone repulsions 
lowering the overall energy of the RNP complex7,20,21. In vitro, these properties induce a massive 
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co-aggregation of recombinant NCp7 and NCp9 with NA templates5,8,22. This “molecular gluing” 
capability guides the matchmaking/NA chaperone activity by facilitating intra- and 
intermolecular RNA-RNA interactions required for functional gRNA folding23. Such crowding 
effects rely on basic residues particularly concentrated in the two small flexible domains, the (1-
14) N-terminal domain and the (29-35) linker between the ZFs20. NCp15 shows slightly different 
NA binding and chaperone properties but is essentially characterized by a reduced ability to 
aggregate NA5,8,24, properties recently correlated with a direct fold-back contact between the p6 
and ZF domains8. NCp9 shows an enhanced NA affinity due to a slower dissociation rate, as well 
as dramatically enhanced NA aggregating activities5,8,21. Alanine substitution of acidic residues 
in p6 converts NCp15 to a NA-aggregating protein similar to NCp9, while addition of a p6 peptide 
lowers the RNA chaperone activity of NCp7 in vitro8. This suggests that SP2 contains an 
additional NA-interaction domain, which may be masked or modulated with another NCp7 
domain by intra- or intermolecular protein contacts between p6 and the NC domain.  
HIV-1 maturation is mandatory for viral dissemination following sequential processes of 
protein and RNA self-assembly, coordinated in space and time by the enzymatic activity of viral 
PR9,10,25. The slow in vitro kinetics of Gag proteolysis supports a general scheme for PR to be 
auto-processed during the completion of budding thus driving viral maturation within free, 
released particles in a computed time-scale close to 30 min26. This model is, however, inconsistent 
with many observations from electron microscopy that shows i) a huge majority of free but freshly 
released particles in a mature form containing condensed RNP27, ii) both capsid and budding 
defects in presence of PR inhibitors28, and iii) budding and maturation defects for critical NC 
mutants, whereas Western blots from cell extracts detects PR-processed Gag products27. Such 
findings suggest a much closer overlap between budding and maturation than generally supposed. 
Importantly, suppressing both PR cleavage sites in NCp15 abolishes viral infectivity13,29 and 
results in an abnormal virion core morphology13. In contrast, suppression of the NCp7-SP2 
cleavage site shows little effect on virus morphology and infectivity in single-cycle assays, but 
reverts to WT (e.g. containing NCp7) after several rounds of infection29. A “roadblock” 
mechanism affecting RT activity on a NA template has been shown to be imparted by NCp9 as 
well as by NCp15, which could limit large-scale viral replication, highlighting NCp7 as the 
optimized cofactor for accurate RNP folding and viral fitness14.  
The present study highlights how HIV-1 gRNA becomes condensed by NC proteins 
through the action of the RNP-sequestered PR enzyme. Reconstituted systems that model non 
sequence-specific binding on a large scale allowed us i) to detail the quinary effects and their 
variations engaged in this dynamic process as well as ii) to focus on PR action in such a gluing 
context. 
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METHODS 
Proteins, Nucleic Acids and Reagents.  
Proteins. The HIV-1 NC proteins and proviral plasmids were based on the pNL4-3 sequence 
(GenBank accession number AF324493). Recombinant wild-type and mutants of NCp7, NCp9 
and NCp15, respectively 55, 71 and 123 amino acids in length, were expressed and purified as 
described8,30-32. The CA-SP1-NC-SP2-p6 protein expression construct was generated by PCR 
amplifying pNL4-3 using GagDMA sense primer 5'-GAT CTG GGT ACC GAG AAC CTC TAC 
TTC CAG ATG ATA GTG CAG AAC, NL43 OCH antisense primer 5'-GCT TGA ATT CTT 
ATT GTG ACG AGG GGT CGC TGC and cloning the resulting product into the homologous 
KpnI and EcoRI sites of pET32a (Novagen, Madison, WI).  Expression construct for NCp15(1) 
(expressing NCp15 that can be cleaved only to NCp9) and NCp15(2) (expressing uncleavable 
NCp15) were generated starting with the NC-SP2- and NCp15-containing proviral plasmids of 
Coren et al. 29, respectively.  The two constructs were generated by PCR amplifying the 
appropriate plasmids with NL4-3 NC sense primer 5'-CGT GGG ATC CTT AGA GAA CCT 
CTA CTT CCA GAT ACA GAA AGG CAA TTT TAG, NL4-3 NCp15 antisense primer 5'-GTA 
CGT GTC GAC TCT CTA ATT ATT GTG ACG AGG GGT CGC T and cloning into the 
homologous BamHI and SalI sites of pET32a.  Site-directed mutagenesis of the wild-type NL4-
3 NCp7 construct to generate the K3A/F6A/Q9A mutant was performed using the Agilent 
QuickChange Site-Directed Mutagenesis kit, with verification by NA sequence analysis, for the 
generation of the recombinant expression plasmid, as described 33.  The K3A mutation results 
from changes to nucleotides 1927 through 1929 from AAA to GCC, F6A results from nucleotides 
1936 and 1937 being changed from TT to GC, and Q9A results from nucleotides 1945 and 1946 
being changed from CA to GC. Proteins were expressed and purified as described8,30-32.  Proteins 
were stored lyophilized and then suspended at a concentration of 1 mg/mL in a buffer containing 
20 mM HEPES pH7.5, 50 mM sodium acetate, 3 mM DTT, 20% (v/v) ethylene glycol, 200 µM 
ZnCl2 and stored at -20°C. The concentrations were determined by measuring the UV absorbance 
at 280 nm using the following extinction coefficients: NCp7 and NCp7 mutants: 5690 M−1. cm−1; 
NCp9: 11,380 M−1. cm−1; NCp15: 12,660 M−1 .cm−1.  HIV-1 PR was expressed in E. coli 
Rosetta(DE3)pLysS strain (Novagen) as inclusion bodies using the expression vector pET-9 and 
purified as described34,35. The PR domain used here bears the Q7K/L33I/L63I and C67A/C95A 
protective mutations to respectively minimize autoproteolysis15 and prevent cysteine-thiol 
oxidation36. PR was suspended, adjusted to 10-20 µM concentration and stored at -80°C in 50 
mM sodium acetate pH5.5, 100mM NaCl, 1 mM DTT, 0.1 mM EDTA, 10% (v/v) glycerol. 
Nucleic Acids. The circular 7,249 nt M13 ssDNA (m13mp18) was purchased from Bayou 
Biolabs, the 3,569 nt MS2 RNA from Roche GmBh. Linear m13mp18 molecules were generated 
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by annealing a complementary oligonucleotide to form a restriction site for BsrB I (NEB) as 
described37. The oligonucleotides poly d(A)13 and TAR-RNA (27 nt, 5’-
CCAGAUCUGAGCCUGGGAGCUCUCUGG-3’), were purchased from Sigma-Aldrich, the 
short RNA fragments corresponding to individual stem-loop motifs of the Psi region: SL1 (17 nt), 
SL2 (23 nt), SL3 (14 nt) and SL4 (24 nt) were purchased (Microsynth) and purified by HPLC 
(ÄKTA design-Unicorn) on a PA-100 anion exchange column (Dionex). Plasmids used for in 
vitro transcription of HIV-1 RNAs used in this study have been described previously38,39. Briefly, 
the pJCB vector was linearized with AflII, XbaI, BssHII, RsaI, or PvuII, and used as templates 
for the synthesis of RNAs 1-61, 1-152, 1-278, 1-311 and 1-615, respectively, by in vitro run off 
transcription using bacteriophage T7 RNA polymerase, followed by purification using size 
exclusion chromatography as described previously 40. Likewise, plasmid pmCG67 was linearized 
with AvaII or SalI to produce RNAs 1-1333 and 1-4001, respectively. RNA 1-102 was obtained 
from a PCR product corresponding to the HIV-1 MAL sequence.  
NP complex assembly and electrophoretic mobility shift assay 
Unless stated otherwise, electrophoretic mobility shift assays (EMSA) contained 1 ng/µL NA 
templates (0.4 nM) in 20 µL and were performed at 37 °C in a binding buffer containing 20 mM 
Tris-HCl pH 7.4, 1 mM MgCl2, 100 mM NaCl, 1 mM DTT. NCp were diluted on ice in the 
reaction buffer. For reactions using NCp15, the buffers were supplemented with 0.1% (w/v) 
Tween 20. Reactions were initiated by addition of NC as appropriate and terminated at 30 min. 
(unless stated otherwise) by chilling the tubes on ice and addition of 10% (v/v) a loading buffer 
(30% glycerol, 0.01% xylene cyanol, 10 mM Tris-HCl pH 7.4). Samples were then fractionated 
on 25 cm-long, 1% (w/v) agarose gels (SeaKem LE Agarose, Lonza) in 0.5x TBE. Gels were run 
in a Sub-Cell GT cuvette (BioRad) for 17-18 hr at room temperature at 3 V/cm, stained with 
SybrGold (Molecular Probes) and scanned for fluorescence using a Typhoon 8600 (GE 
Healthcare). All experiments were performed at least in triplicate. 
Dynamic Light Scattering 
Dynamic light scattering (DLS) measurements were carried out in 20 mM Tris-Acetate pH 7.4, 
50 mM sodium acetate and 1 mM DTT, using 2.5 ng/µL M13 ssDNA. Experiments were 
performed with a Zetasizer Nano-ZS (Malvern Instruments Ltd) and high precision cells (QS 3.0 
mm, Hellma Analytics). Measurements were performed at 37°C, 20 min after addition of the 
indicated amount of NCp and analyzed by the Dispersion Technology Software provided.  
AFM imaging  
NC:NA complexes were assembled under conditions used for EMSA with 1 ng/µl of M13 ssDNA 
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and in a binding solution containing 10 mM TrisAcetate pH 7.0, 50 mM sodium acetate, 2.5 to 5 
mM magnesium diacetate and 0.5 mM TCEP. A freshly cleaved muscovite mica surface was pre-
treated for 2 min with a fresh dilution of spermidine (50 µM), extensively rinsed with water and 
dried under a nitrogen flow41. A 5 µL-drop of the NP complexes was deposited on the surface and 
incubated for 3-5 min and dried with nitrogen gas. AFM images were carried out in air with a 
multimode scanning probe microscope (Bruker) operating with a Nanoscope IIIa or V controller 
(Bruker) and silicon AC160TS cantilevers (Olympus) using the tapping mode at their resonant 
frequency. The scan frequency was typically 1.0 Hz per line and the modulation amplitude was a 
few nanometers. A second order polynomial function was used to remove the background with 
the AFM software.  
Proteolysis assays 
NC cleavage and SDS-PAGE analysis. 
A proteolysis assay of NCp15 bound to ssDNA using recombinant PR was showed previously 6. 
The assay was optimized in this study to ensure a detailed analysis of the reaction using SDS-
PAGE electrophoresis (Supplementary Fig. 3a-b). Peptides were quantified by fluorescent 
staining, which allowed accurate measurements in the 25-500 ng range, in agreement with our 
NP complex analysis. The standard proteolysis assay contained NCp proteins (6 µM) incubated 
with NA for 5 min at 37 ºC in 10 µl of a PR buffer (MES 50 mM/Tris variable to adjust pH, NaCl 
100 mM, DTT 2 mM, BSA 50 µg/ml). Next, PR was added, unless otherwise indicated, at a 
concentration of 600 nM. Reactions were stopped by addition of a SDS-PAGE loading buffer and 
heat denaturation (5 min at 95°C), followed by 1 h incubation at 37°C in presence of 300 mM 
Iodoacetamide, which prevented protein oxidation (Supplementary Fig. 3a). Samples were 
separated on 20% acrylamide gels using Tris-Tricine SDS-PAGE in a Hoeffer MiniVE system. 
After migration at 160 V for 2.5 hr, the gels were fixed by 40% ethanol/10% acetic acid for 1 hr 
and stained overnight in 200 mL of Krypton Fluorescent gel stain (Life Technologies) diluted 
1/10 in water. Gels were then rinsed with 5% acetic acid and incubated in milliQ water for 30 min 
before scanning with a Typhoon 8600 imager. Fluorescence counts were quantified using the 
ImageQuant software (GE Healthcare). Apparent Vmax was measured by dividing the product 
concentration by the time of incubation with [product]/ [S0] product ratio less than 30%. The PR 
cleavage assay of Fig. 1e-f was performed by incubating NCp15 (750 nM) and M13 ssDNA 
(1nM) in MES 50mM/Tris pH6.25, 100 mM NaCl, 4 mM MgCl2, 2 mM DTT for 15 min at 37°C 
in 50 µL. PR (35 nM) was added and the cleavage was carried out at the indicated times. Each 
reaction was stopped by chilling the tubes on ice while a 5 µl-drop was used to prepare mica for 
AFM, 15 µl were loaded on the gel for EMSA and the remaining 30 µl were used for SDS-PAGE 
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after treating the samples as previously indicated. All experiments were performed at least in 
triplicate. 
FRET assay. The proteolytic activities of PR were determined using the principles of Förster 
resonance energy transfer (FRET) by cleavage of a fluorogenic peptide substrate DABCYL-g-
abu-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS (Bachem, Germany) with DABCYL, 4-(4′-di- 
methylaminophenylazo)benzoyl; g-abu, g-aminobutyric acid; EDANS, 5-[(2-aminoethyl)amino] 
naphthalene-1-sulfonic acid. Incubation of PR with the probe resulted in specific cleavage at the 
Tyr-Pro bond and a time-dependent increase in fluorescence intensity that is linearly related to 
the extent of substrate hydrolysis. Kinetic experiments were carried out at 30°C in 150 µL of the 
PR buffer (50 mM MES-Tris combination, 0.1 – 1 M NaCl, pH adjusted between 5 and 7), 5.2 
µM of the probe and 10-50 nM of PR. The probe was first dissolved in DMSO. The final DMSO 
concentration was kept at 3 % (v/v). Fluorescence intensities were measured in a BMG Fluostar 
microplate reader. Delay time for the reaction start was calculated as the reaction slope intercept 
with the x axis. All experiments were performed at least in triplicate. 
Electron microscopy of HIV-1 particles 
Maturation mutants. Mutant virions accumulating NCp15 or NCp9 were produced by 
transfection of mutated pNL4-3 proviral plasmids as described 29. Plasmids were transfected into 
HEK 293T cells using Mirus TransIT 293 (Mirus Bio LLC, Madison, WI) according to the 
manufacturer’s instructions. 48 h culture supernatants were clarified and virions ultracentrifuged 
and examined by electron microscopy as described previously 42,43. At least 180 particles were 
analysed on the criteria that they were enveloped and a contrast was visible inside. Then the 
subpopulation of the diffuse cores instead of thin, dark spots was scored with, as discriminating 
criteria, a diameter equal or larger than 70% of the internal diameter of the particle. 
Viral particles produced from latently infected cells.  Briefly, the latently infected ACH2 cells 44 
were grown under standard conditions, were plated onto 10 cm cell culture dishes at densities of 
4x106 cells and incubated with or without PR inhibitor (10 µM Lopinavir, Sigma). HIV production 
was activated by adding Vorinostat (10 µM; Sigma). After 2 days, ACH2 cells were fixed with 
2.5% glutaraldehyde, washed, dehydrated, embedded in epoxy resin according to standard 
procedures 45. Electron microscopy images were obtained with a Tecnai Spirit microscope coupled 
with a 1376 x 1024 pixel CCD camera (FEI, Eindhoven, The Netherlands). We analysed 500 
particles attached to the membranes after normal production and 120 after production in presence 
of Lopinavir (respectively 46.1 and 53% of the total number of detectable particles). Within each 
attached population, mainly 91 % particles were identifiable, 89.6 % containing a dark spot 
compared to only 1.4 % immature for the normal population, while dark spots were not visible 
after viral production in presence of Lopinavir. 
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Molecular Dynamics Simulations and Analysis 
Molecular dynamics simulations followed a previously well-established protocol 46. An initial 
structure was prepared for the NC-SP2 (RQAN-FLGK) octapeptide ligand in apo-form. Atomic 
coordinates for the octapeptide were extracted from the 1TSU crystal structure46,47.  The standard 
AMBER forcefield (ff03)48 was used to describe all parameters. The system was solvated using 
atomistic TIP3P water and then electrically neutralized with an ionic concentration of 0.15 M, 
resulting in a fully atomistic, explicit solvent system of approximately 14,000 atoms. Conjugate-
gradient minimization was performed.  The SHAKE algorithm was employed on all atoms 
covalently bonded to a hydrogen atom. The long range Coulomb interaction was handled using a 
GPU implementation of the particle mesh Ewald summation method (PME). A non-bonded cut-
off distance of 9 Å was used with a switching distance of 7.5 Å.  During equilibration the position 
of all heavy peptide atoms was restrained by a 0.5 kcal/mol/Å² spring constant for all heavy 
protein atoms and the system evolved for 10 ns with a timestep of 4 fs. The temperature was 
maintained at 300 K using a Langevin thermostat with a low damping constant of 0.1/ps and the 
pressure maintained at 1 atm for both systems. The system was then equilibrated for 10 ns of 
unrestrained simulation in the canonical ensemble (NVT) with an integration timestep of 4 fs. 
The final coordinates were used as input for production simulations. All subsequent simulations 
were carried out in the NVT ensemble. All production simulations were carried out using 
ACEMD49.  An ensemble of 10 x 1 µs production simulations was performed. Coordinate 
snapshots from production simulations were generated every 10 ps, resulting in a ensemble of 106 
conformers for analysis. 
The octapeptide was relabelled as R52-Q53-A54-N55-F56-L57-G58-K59. The conformer 
ensemble was analyzed in a reaction coordinate space consisting of two order parameters:  the 
K59-Q53 Cα distance (dKQ) and  K59-F56-Q53 Cα angle (θKFQ). The potentials of mean force 
(PMF) was calculated by binning the ensemble data into microstates corresponding to the given 
reaction coordinate space and then calculating the mole fraction (ρ) of each microstate using PMF 
= -kBTln(ρ), where kB is the Boltzmann constant and T the temperature.  Corresponding order 
parameters were calculated for each of the NMR conformers in PDB 1F6U of the NC N-terminus 
where dKQ was the K3-Q10 Cα distance and the θKFQ K3-F6-Q9 Cα angle. Conformers were then 
aligned to the NC N-terminus from PDB 1F6U by the Cα atoms of K59-R52 mapped to K3-R10 
of 1F6U. The Cα RMSD was then calculated as a third order parameter (dn), its probability density 
was determined by binning (ρ(dn)) and conformers within the thresholds of 1 Å, 1.5 Å and 2 Å 
extracted and mapped back to the dKQ - θKFQ  reaction coordinate space. 
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Results 
 
We first focused on the quinary interactions and the architectural behavior of NC:NA 
complexes by a combination of electrophoretic mobility shift assay in agarose gels (EMSA), 
atomic force microscopy (AFM) and dynamic light scattering (DLS). Examining RNPs with large 
ssNA templates under increasingly dilute conditions interestingly switched NCp7 binding from 
NA aggregation (quinary interactions) to intramolecularly-folded NP condensates (Fig. 1b). 
NCp7 binding titrations on a circular M13 ssDNA showed a progressive process of ssDNA 
migration acceleration in a gel (Fig. 1c), seen by AFM as tightly compact NP structures formed 
of folded DNA strands coated and bridged with protein (Fig. 1d). Maximum ssDNA compaction 
was reached for saturating amounts of one NCp7 over 8-10nt22.  Additional protein resulted in the 
fusion of these NP condensates into very high molecular weight structures that exhibited smearing 
during electrophoresis.  AFM showed a progressive accumulation of protein clusters covering the 
lattices while the branched and secondary structures of the ssDNA appeared melted or absent, and 
rather bridged into nucleofilament-like structures (Supplementary Fig.2). Omission of 
magnesium in the buffer (Fig. 2g-i) or an excess of NCp7 resulted in fusion of the individual 
condensates into huge macrostructures with a spheroid shape comparable with previously 
described NC:NA aggregates5,6,21. NCp7 mobility was deemed necessary since this fusion was 
not observed and condensation was delayed at 4°C24,31 (Supplementary Fig 1a). The kinetics of 
the reaction indicated fast intramolecular condensation and a slow process of NP condensate 
fusion (Supplementary Fig. 1b). Low monovalent salt concentration increased NCp7/ssDNA 
aggregation and a strong electrostatic competition was observed with Na+ or Mg2+, as expected21,50 
(Supplementary Fig. 1c). Mutations of key aromatic residues, Phe16 and Trp37 (Supplementary 
Fig. 1d-e) demonstrated that ssDNA condensation not only depend on phosphate backbone 
neutralization but also on base capture by the ZF domain. The apo-protein SSHS NC mutant30 
promoted DNA aggregation without acceleration of DNA mobility as expected for polycation-
induced NA aggregation51. Finally, Ala substitution of basic residues in the N-terminal domain 
and the linker demonstrated these residues to be essential for ssDNA condensation, as expected. 
Strand circularity, e.g. the ssDNA topological constraint, favored intramolecular ssDNA bridging, 
whereas intermolecular ssDNA-NC-ssDNA interactions were enhanced with linear M13 ssDNA 
or MS2 RNA (Supplementary Fig. 1f), which demonstrated protein-NA networks involving NA-
protein-NA and protein-NA-protein interactions, as proposed previously52. 
Binding of NCp9 yielded fast-migrating NP condensates for the lowest protein 
concentrations (Fig. 1c), indistinguishable by AFM from those formed with NCp7 
(Supplementary Fig. 2f). However, NCp9-driven NA condensation was seen dramatically 
associated with a huge fusion process by EMSA (Fig. 1c), DLS (Fig. 2i) and AFM (Fig. 1d, 
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Supplementary Fig. 2f-g). Linearity of the ssDNA template resulted in a huge aggregation, 
demonstrating the presence of an additional NA binding site in SP2 reinforcing NA-NC-NA 
networks (Fig.2). In contrast to NCp9 or NCp7, reaching a plateau of one NCp15 per 10-12nt, 
NCp15 binding to any of the three templates yielded NP complexes of lower gel mobility upon 
protein addition (Fig.1c), similar to canonical ssDNA binding proteins41. AFM visualization 
showed passive ssDNA coating instead of bridging compaction within individual complexes for 
limiting NCp15 concentration, which then led to globular structures at saturation (Fig.1d, 
Supplementary Fig. 2h-i). NCp15 and NCp7 retain equivalent net charges14 (NCp15 pI 9.93; 
NCp7 pI 9.59). Therefore, NCp15 binding does not actively compact and aggregate ssNA, 
confirming previous results5,8. With free NCp15, p6 has been proposed to bind to the NC domain8. 
Like NCp15 from HTLV-153, HIV-1 NCp15 binding to NA might invoke quinary intermolecular 
p6-NC contacts instead of quinary NA-NC contacts. These interactions may freeze these globular 
structures and mask or block the NC residues responsible for NA compaction/aggregation. 
Followed by EMSA, SDS-PAGE and AFM, the dynamics of quinary NC-NA interactions through 
cleavage of M13 ssDNA-bound NCp15 is verified (Fig. 1e-f) from weak, in the presence of 
NCp15, to strong with NCp9, and moderate with NCp7. From globular (NCp15), individual NP 
complexes are progressively converted into intramolecular condensates (NCp7) after an 
intermediate step of fusion (NCp9).          
A superposition of the N-terminal 310 helix from the NMR structures of NCp7-SL2 and 
NCp7-SL3 complexes is shown in Fig. 2a-b and reveals two slightly different NA backbone 
binding motifs for this domain, which could be virtually sandwiched between two RNA stems, 
providing a bridge to form RNA-NC-RNA networks52. Three additional basic residues over the 
sixteen present in SP2 poorly explain the dramatic enhancement of the NA gluing capabilities of 
NCp9. Examination of the NCp9 primary sequence reveals that the NC-SP2 cleavage site 
surprisingly contains 5 of the 8 residues of the NCp7 SL2-binding motif Lys-Gly-x-Phe-x-x-Gln-
Arg, but oriented in reverse, from C- to N-terminus (Fig. 2a, d). To determine if conformers of 
this sequence would be compatible with a NA binding site structurally similar to those of the N-
terminal 310 helix, we performed all-atom molecular dynamics (MD) simulations of an NC-SP2 
octapeptide cleavage site. Results of the simulations showed a large conformational area 
corresponding to a predominantly disordered peptide, similar to other disordered peptide regions 
in HIV-154,55. However, three conformer populations were found to lie within 2 Å to 1 Å RMSD 
with respect to the N-terminal 310 helix (Fig. 2c-e), as expected. The K3A/F6A/Q9A-mutation in 
NCp7 mostly abrogated ssNA aggregation but maintained ssDNA M13 condensation, suggesting 
this triad to be mostly involved in quinary interactions stabilizing NA:NC networks (Fig. 2f-h). 
A DLS analysis in low magnesium finally demonstrated a NCp7/NCp9-driven compaction of 
M13 ssDNA from 100 nm to 70 nm, followed by a massive fusion/aggregation of these complexes 
(Fig. 2i). In contrast, the K3A/F6A/Q9A NCp7 mutant was strongly defective in the 
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fusion/aggregation process. Altogether, these data strongly support a model where the Lys(3/59)-
Gly(4/58)-x-Phe(6/56)-x-x Gln(9/53)-Arg(10/52) octad would act in both NCp7 and NCp9 as a 
quinary interaction module, establishing bridges between NC-NA complexes at NA saturation 
(Fig.6a). These positions are highly conserved amongst all the HIV-1 subtypes, except at position 
3 where the conservative K and R residues are found equiprobable.   
Followed by SDS-PAGE under conditions optimized for peptide quantification 
(Supplementary Fig. 3a-b), in vitro processing of the C- and N-terminal extremities of the NC 
domain in an environment unfavorable for PR dimers (0.1 M NaCl, pH 6.25) reveals a dramatic 
acceleration of NCp15, NCp9 and NCp7 production in the presence of ssNA templates (Fig.3a, 
Supplementary Fig. 3c-e). 100% of ssDNA- or RNA-bound NCp15 were cleaved in two distinct 
steps producing NCp9 and then NCp7 within minutes, confirming a distributive reaction without 
consecutive cuts upon the same NCp15 copy (Supplementary Fig. 3c). Without NA, complete 
NCp15 cleavage occurred but at a slower rate, only under acidic (pH 5.0) and high salt (1.5M 
NaCl) conditions (Supplementary Fig. 3d), also concomitantly producing a shorter product 
(NCp7*). Similar effects were observed with NA for NCp9 cleavage (Supplementary Fig. 3e) and 
the NC-SP2 cleavage appeared 2-3 times slower than that of SP2-p6 either starting from NCp15 
or NCp9, but was completed in minutes, much faster than previously shown16. MS2 RNA 
activation also occurs for the SP1-NC site of a GagΔMA protein (CA-SP1-NC-SP2-p6), 
confirming recent results using a GagΔp6 (MA-CA-SP1-NC-SP2) protein11 (Supplementary Fig. 
3f).  
We focused on the NC-ssNA NP assemblies and their influence on NCp15 cleavage at 
pH 6.25 and 0.1 M NaCl. We first compared the influence of large-scale assembly of NCp15 on 
M13 ssDNA or MS2 RNA versus stoichiometric complexes formed between NC and a TAR RNA 
stem-loop (Supplementary Fig. 4a). The NA concentrations were varied for a fixed concentration 
of NCp15. A biphasic effect was observed in presence of either long ssNA, PR reaching maximal 
activity when NCp15 saturated the ssNA lattices (Supplementary Fig. 4b). A substantial reduction 
in PR efficacy was observed upon dispersion of NCp15 over the lattice, even though cleavage 
was maintained at a much higher level than in absence of NA. In contrast, neither a biphasic effect 
nor a rapid rate was observed in presence of the TAR-RNA. This NA chain-length effect was next 
followed for NCp15 cleavage, maintaining equal nt concentration for various HIV-1 RNA stem-
loops and fragments from 61 to 615 nt (Fig. 3b, Supplementary Fig. 4c). A weak NC substrate, 
d(A)13 oligonucleotide, was ineffective in stimulating PR activity, whereas the TAR and SL3 RNA 
led to significant, but incomplete stimulation of the reaction. Above a critical threshold (~50 nt-
length) and for a pH optimum around 6.3 (Supplementary Fig. 4e-f), PR activity scaled non-
linearly with RNA length irrespective of biological origin (Fig. 3b). Without NA, a 5-minute 
incubation between NCp15 and PR in 0.1 M NaCl at pH 6.25 resulted in no cleavage, while the 
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addition of MS2 RNA immediately boosted the reaction (Supplementary Fig. 4d). Diluting PR 
for fixed NC:PR (10:1) and NA:NC (20nt.:1) ratios revealed a process resistant to dilution for NA 
larger than 615nt (T1/2 from 0.15 to 1 minute), whereas a strong rate decrease was observed for 
TAR or cTAR structures (T1/2 extrapolated to 3 h when considering the first quarter of the reaction; 
(Supplementary Fig. 4e). A regular decrease at pH 5.0 and 1.5 M NaCl was observed in absence 
of NA (T1/2 from 4 to 25 min). These large NA chains greatly stimulated NCp15 cleavage at 0.1 
M salt, with a remarkable pH optimum between 6.0 and 6.5 (Supplementary Fig. 4f). The NCp7* 
extra-cleavage, previously described, corresponds to a site at position 49-50 as a result of ZF 
destabilization at low pH56. This product was examined in two NCp15 cleavage mutants 
(Supplementary Fig. 4g) and was due to the cumulative effects of both MS2 RNA and acidic pH, 
which clearly “overcut” the NC domain at pH 5.4. A mildly acidic pH appears therefore beneficial 
in reducing irregular cleavages of NCp7 upon high PR turnover. With such optimized conditions 
that satisfy both PR efficiency and NC folding while restricting NCp7 cryptic site cleavages, we 
confirmed the RNA length effect for the NCp9-to-NCp7 reaction (Supplementary Fig. 4h-i), 
leading to a maximal observed rate close to the T1/2-value of NCp15-to-NCp9 reaction rate, under 
conditions where NCp9 and NA appeared strongly aggregated (see Fig. 1). In conclusion, in 
presence of 1:1 NC ligands (TAR, cTAR, SL3), bound NCp15 appears almost individually 
distributed in the reaction mix and allow a reaction-diffusion mechanism that accelerate PR 
turnover but under conditions where native PR is much less stable. Any substance able to increase 
the local concentration of either the substrate or the enzyme, or both, drives the reaction in the 
forward direction enhancing enzyme turnover. As such, ssNA length-dependent activation 
engages a NC crowding effect with NCp15 molecules coating the NA lattice and forming clusters 
trapping PR independently of the NP complex concentration. These NA-scaffolded clusters allow 
faster PR turnover, making both SP2-p6 and NC-SP2 cleavages much more efficient. In other 
words, the NA gluing capabilities of the NC domain induce an RNA-driven sequestration effect 
on PR. 
To better understand this sequestration phenomenon, we used a FRET-based assay that 
measures the cleavage rate of a MA-CA octapeptide probe in presence of NA and/or NCp15. The 
assay firstly confirmed the reduction of PR activity upon pH increase and salt dilution 
(Supplementary Fig. 5a-b). The M13 ssDNA appeared as an effective substitute to high salt and 
boosted PR activity by a factor of 10 at pH 5.0, three times greater than in presence of 1.5 M 
NaCl. A similar effect also occurred at pH 6.25, although PR activity was strongly attenuated. 
These results confirmed that non-specific PR-NA interactions result in enzyme activation12. 
Adding an equimolar amount of NCp15 at pH 5.5 did not affect the reaction. In contrast, addition 
of NCp15 bound to ssDNA resulted in a total inhibition of the octapeptide cleavage for ~5 min, 
before reaching a velocity analogous to that measured in presence of ssDNA alone (Fig. 3d, 
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Supplementary Fig. 5c). PR is thus sequestered into the NP complex and completes NCp15 
processing prior to cleaving the MA-CA peptide at a rate comparable with ssDNA alone, the delay 
time being directly proportional to NCp15 concentration with a fixed NCp15:ssDNA ratio (Fig. 
3d). These data were interpreted by devising a two-substrate model of NA-modulated enzyme 
kinetics (Supplementary Note), which partitions the reaction volume between distinct regions that 
are either occupied (pervaded) or unoccupied (un-pervaded) by NA (Fig. 4a). Reacting species 
(S1: MA-CA, S2: NCp15, E: PR) exhibit equilibrium absorption (KS1, KS2 and KE) between these 
regions due to nonsequence-specific NA-binding. In our model, the enzyme escape rate depends 
on RNP contiguity - the contiguous number (c = [NCp15]nl/[nt]) of NCp15 molecules bound per 
NA and not just chain length or NC-NA loading ratio alone. The phase transition is consistent 
with a minimum critical contiguity threshold (ccrit) required to alter enzyme escape rate. 
Contiguity is still length dependent: fitting a reduced single-substrate model onto the experimental 
data (Fig. 4b) yields non-linear dependence of KE on contiguity with exponent ξ ~0.4. and ccrit ~3. 
By expanding to a two-substrate competitive assay (Supplementary Note) and incorporating the 
effects on differential enzyme decay (Fig. 4d), our model is fitted to, and is compatible with the 
observed sequestration effect (Fig. 3c) giving ξ ~1.2 and ccrit ~ 3. Sequestration is thus due to 
reduction in the RNP contiguity across the time-course of the reaction – initially the enzyme is 
absorbed into the RNP (KE >>1), after significant processing it is expelled (KE<<1). The model 
follows NCp15 cleavage directly (Fig. 4c) and when scaled to in virio concentrations of enzyme 
and substrate as well as increased NA length, predicts a core condensation time of ~5 min (Fig. 
4e). Our model shows that local crowding within the RNP induces cumulative non-linear effects 
on non-specific enzyme binding. The absorption equilibrium constant itself depends on this local 
environment, consistent with quinary interactions between PR, RNA and NCp1557. 
In order to approach this process of RNP condensation in virio, we finally compared by 
TEM the core content of HIV-1 NL4-3 virus particles assembled with P55Gag containing un-
cleavable NC-SP2 or NC-SP2-p6 sites, thus accumulating NCp9 and NCp15 respectively29 (Fig. 
5a and Supplementary Fig. 6a). More than 90% of both NCp9- and NCp7-containing viruses 
display a morphologically well-formed conical capsid encasing an electron-dark spot 
corresponding to a condensed RNP.  In contrast, more than 80% of the NCp15-containing viruses 
display electron-dark diffuse cores. This demonstrates that the strong-gluing NCp9 intermediate 
actively triggers nucleocapsid condensation, thus reducing the occupied volume and facilitating 
capsid rearrangement. We next imaged plasma membrane-attached particles of HIV-1 virus 
produced from latently-infected ACH2 cells. Washing the cell suspension before fixation 
enriched the proportion of attached particles engaged in budding. In the presence of a PR inhibitor, 
all membrane-attached particles appeared immature with a typical electron-dense Gag shell and 
a bottleneck that characterized budding intermediates (Fig. 5b,d). Without inhibitor, most of the 
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attached particles exhibited a dark spot and a closed envelope (Fig. 5c-d). Therefore, the 
maturation step involving strong-gluing NCp9 occurs visibly in a time frame consistent with both 
the end of budding58-60 and our kinetic model: budding and maturation appear temporally coupled. 
 
Conclusion 
 
We describe in this study HIV-1 nucleocapsid maturation as a dynamic RNA granule 
processing, involving differential RNA binding activities of the NC domain that are dependent 
on processing state. Weak NC-RNA contacts fit with the concept of quinary interactions3, 
providing a biological “glue” that leads to gRNA condensation in the context of an RNA-directed 
gel phase2. We propose that this RNP follows a dynamic weak-strong-moderate (WSM) quinary 
model resulting in granular phase-separated RNP condensation (Fig. 6) with a distributive three-
step processing mechanism in the order of SP1-NC, SP2-p6 and NC-SP2. Each step alters NC-
RNA gluing strength within the confined gel phase. The variations in gluing the RNA (in vitro 
condensation plus aggregation) appear therefore directly linked with the number of amino acid 
residues weakly contacting NA chains, these contacts being severely limited in NCp15 due to p6 
interfering with NC-SP2 NA binding8,14 and/or competing with the NA for binding to the NC ZF 
core. We propose that, in addition to the polycationic nature of the NC domain20,22,24,53, two motifs, 
one in the N-terminal 310 helix and the other, an inverted motif in the NC-SP2 junction are 
responsible for NC-NA-NC and NA-NC-NA networks providing the molecular glue. In the 
crowded in virio environment at neutral or mildly acidic pH, our model also involves quinary PR 
sequestration by the RNP, which dramatically enhances the global efficiency of the sequential 
cleavage.  
Our data confirm, first, that RNA-bound NCp15 avoids active RNP condensation within 
the NCp15-gRNA intermediate assembly. The intrinsically disordered p6 likely directs a quinary 
RNA-NCp15 network via NC:p6 intermolecular contacts and weakens the quinary RNA-NC 
interactions. Such assembly is deficient in actively aggregating within the viral core, while it 
should allow the 60 PR available in the particle to efficiently access the 2400 SP2-p6 cleavage 
sites and to jump from site to site within close distances (Fig. 6). PR recently was shown to be 
activated by interacting with RNA12. We demonstrate here that fast PR turnover requires RNA-
clustered NCp15 for the enzyme to be sequestrated, enhancing its local concentration and 
allowing it to efficiently cleave the SP2-p6 octapeptide sites.   
We suggest the mechanistic origin of this sequestration to be the dynamic formation of a 
network of quinary interactions, derived from multiple, weakly attractive ternary contacts of PR-
(SP2-p6)-RNA. Whilst the SP2-p6 octapeptide does not directly appear in contact with RNA, the 
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exposed PR basic residues proposed to bind to RNA12 should allow this ternary contact, whereas 
RNA-bound NCp15 should expose its SP2-p6 cleavage site to RNA-bound PR with the NC-SP2 
site being inaccessible. One quinary effect would be that progressive cleavage of the SP2-p6 sites 
within the RNP results in loss of these ternary contacts, driving the change in enzyme absorption 
equilibrium – thus expelling PR from the RNP. Following cleavage of an SP2-p6 site, another 
effect may be a directed, rather than diffusive, propagation of PR. Inaccessibility of NC-SP2 
implies a discrimination process that favors trans PR transfer to neighboring NCp15 molecules 
rather than cis sliding along the NCp9 moiety to cleave the RNA-bound NC-SP2 site, even though 
only 16 aa sequentially separate the two sites. Cleaved p6, already in contact with a neighboring 
NC domain, likely directs the trans event. Both effects are complementary to each other and 
consistent with our model. 
When NCp9 forms, the NC-SP2 octapeptide site should bind more easily to RNA due to 
p6 separation, promoting both the PR recruitment for the NC-SP2 cleavage and the RNA 
condensation in concert with the other critical NC residues. Again a ternary PR-NCp9-RNA 
complex would be required, as the free NCp9 appeared here as a poor substrate for PR, confirming 
previous results16. We propose that the NC-SP2 site is in direct contact with RNA by way of the 
QxxFxxK triad. The critical NC-SP2 octapeptide also binds within the PR internal catalytic site 
for cleavage: this cleavage should require displacement of the bound RNA upon the surface of 
PR allowing a quinary contact between RNA and PR. In addition, longer RNA segments are 
required to strongly enhance NCp9 cleavage suggesting that PR transfers directly from cleaved 
NCp9 (i.e. NCp7) to neighboring NCp9. RNA condensation does not seem to provide any critical 
physical barrier to PR as NCp9 processing appears quite similar whether the reaction starts from 
NCp15 or NCp9 (Fig. 3a). This suggests a perfect fit for ordered turnover by PR from site to site 
with two distinct waves, NCp15-to-NCp9 followed by NCp9-to-NCp7.  
Quinary interactions undoubtedly offer a missing link between molecular and cellular 
biology1-4. In the HIV-1 model, the granulation dynamics shown here opens new avenues at the 
mesoscopic scale to better understand how the surrounding capsid progresses towards a conical 
reassembly and what the implication and relocation of RT and IN proteins are. While both mature 
during GagPol processing, IN has been shown recently to be a key actor in properly coordinating 
RNP granular condensation and capsid reassembly within the viral particle61,62. These dynamics 
also offer new schemes to revisit the proposed implications of HIV-1 Nef, Vif, Tat and Vpr 
auxiliary proteins within the design of an infectious particle63. It strongly argues finally for tight 
control of GagPol incorporation and PR auto-processing supported by the NC domain in GagPol 
during particle formation64,65: this domain should help to position GagPol in the Gag assembly 
facilitating the processed PR directed by the gRNA to digest the Gag-domains NC, SP2, p6.  As 
highlighted by an independent study looking for production of GagPol VLPs without any viral 
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accessory genes 66, the concomitant interactions of the exposed p6 domains with the ESCRT 
components, ALIX and more especially TSG10127,67,68, tightly coordinate complete processing of 
Gag within just a few minutes of particle release. This is in accordance with what we show here, 
namely, the exclusive release and processing of mature HIV-1 particles, 
including a condensed nucleocapsid, accelerated to the same time frame due to a gel phase-
separated effect.  
Finally, we highlight here NC-RNA interactions as highly attractive pharmacological 
targets during particle production69 and we shed light on new approaches for studying RNP 
assemblies where RNA provides a scaffolding role for crowded architectures, emergent 
mechanisms and their quinary regulation2,4,70. 
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Figure 1 | WSM-gluing properties of NCp15, NCp9 and NCp7. a, Sequence of NCp15 and PR 
cleavage sites. b, on agarose gel, the electrophoretic migration of M13 ssDNA:NCp7 NP 
complexes (1NCp7/10nt) for serial dilutions of both DNA (expressed in total [nt]) and NCp7 
shows a switch from aggregation to intramolecular condensation. Position of the unbound circular 
(circ) ssDNA and trace of linear (lin) molecules is indicated on the left. c, M13 ssDNA:NCp15 
complexes are up-shifted by EMSA upon increasing protein concentration, while ssDNA:NCp9 
and ssDNA:NCp7 complexes are accelerated, thus compacted, and aggregate after NA saturation. 
RNC/nt indicate the protein/nucleotide ratio. d, Condensation of M13 ssDNA by NCp7 and NCp9 
is visualized by AFM and show intramolecular condensates involving DNA strand bridging. 
NCp9 aggregate these condensates while ssDNA:NCp15 complexes appear globular. The 
cleavage kinetics of M13 ssDNA-bound NCp15 by PR was followed by EMSA (e), SDS-PAGE 
and AFM (f), showing weak-strong-moderate gluing properties of NCp15, NCp9 and NCp7, 
respectively, along the sequential maturation of NCp7 by PR. In the EMSA gel are shown NP 
complexes migration controls at pH 7.4 and pH 6.25 (optimal for PR cleavage).  
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Figure 2 | NC:NA quinary interactions. a, The N-terminal 310 helix and the NC-SP2 
cleavage site contain DNA strand bridging motifs. The Wenxiang diagram shows the residues 
of the N-terminal 310 helix in contact with SL3-RNA (red) or SL2-RNA (blue). The diagram 
of the 53-60 sequence shows the Q53-F56-G58-K59 motif mirroring the K3-G4-F6-Q9 motif 
in contact with SL2. The schematics indicate possible NA-NC-NA network assemblies 
provided by such NA binding domains. b, Superposition of NC-SL3 (PDB ID: 1A1T) and 
NC-SL2 (PDB ID: 1F6U) N-terminal domain in complex with their respective NA ligands.  
c, The NC-SP2 apo-octapeptide exhibits substantial flexibility and is free-energetically 
dominated by a turn-like structure with dKQ ~ 4-6 Å structure θKFQ ~ 20°-40° yielding a PMF 
of 5-7 kcal/mol. The apo-ensemble conformers sample a region with  dKQ ~ 10-12 Å with θKFQ 
~ 140°-180° with less frequency (PMF~1-3 kcal/mol) where fit all NMR conformers of 1F6U, 
thus compatible with a 310 helical structure. d, Illustration of best-fitting structural conformer 
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of the 52-59 segment superimposed head-to-tail with the N-terminal domain of 1F6U. e, Three 
conformers populations were found to lie within 2 Å RMSD (9.1x10-5 %), 1.5 Å (1.3x10-5 % 
) and 1 Å (3x10-7 % ) with respect to the N-terminal 310 helix. Mapping the conformers onto 
the dKQ-θKFQ order parameters (blue circles) show they occupy the same region of the 
conformational sub-space. f, K3AF6AQ9A mutations in NCp7 strongly reduced the protein’s 
capability to aggregate circular and linear M13 ssDNA or MS2 RNA (compare with Fig. 1c, 
NCp7). g-h In the absence of magnesium, wt-NCp7 (1NCp7/10nt) strongly aggregates M13 
ssDNA whereas the K3AF6AQ9A mutant preferentially condenses the ssDNA. i, By DLS in 
the absence of magnesium, M13 ssDNA (black) is condensed by the K3AF6AQ9A NCp7 
mutant (orange), condensed and next aggregated by NCp7 (green) or aggregated by NCp9 
(blue).  
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Figure 3 | Nucleocapsid maturation is promoted by NA through sequestration of PR. a, NC 
binding to M13 ssDNA or MS2 RNA strongly activates in vitro cleavage of SP1-NC, SP2-p6 and 
NCp7-SP2 sites by PR under unfavourable conditions (pH 6.25 and 0.1 M NaCl; see 
Supplementary Fig. 3a-b for assay details). b, In vitro cleavage of NCp15 by PR is activated in a 
ssNA length-dependent manner. c, Cleavage of a MA-CA probe by PR is activated by ssDNA 
and is delayed in presence of ssDNA:NCp15 complexes as the latter sequester PR. MA-CA 
proteolysis was followed by FRET. d, Delay of the FRET probe cleavage extrapolated from (c) 
as a function of M13 ssDNA:NCp15 complex concentration (RNCp15/nt =1/20).  
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Figure 4 | Kinetic model of two-substrate (S1, S2) processing by an enzyme (E) in a RNP. a, 
Reaction rate is governed by a combination of effective concentration in a volume domain and 
absorption kinetics for different species. For KE>> 1, PR is sequestered into the RNP-pervaded 
volume whilst for KE << 1 it is forced out. b, A one-substrate model is fit to experimental data to 
determine non-linear (exponent ξ) KE dependence on the contiguous number c of S2 molecules 
bound per NA above a critical threshold, ccrit. c, Fitted two-substrate model of sequestration 
(black) with competitive substrate alone (red)  NA-present competitive substrate (brown) data. 
The early reaction is dominated by high contiguity (c > ccrit, KE >>1) inducing enzyme 
sequestration. This effect dissipates upon processing (c<ccrit, KE <<1). 90% of NCp15 cleavage 
(dashed line) occurs within 400 s. d, Differential enzyme decay: NA stabilizes the PR dimer; the 
NA-absent reaction decays with experimental half-life. e, Scaling to in virio conditions yields 
90% NCp15 processing (purple) within 260 s.  
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Figure 5 | Nucleocapsid condensation within HIV-1 particles depends on NCp15 processing 
and is detectable in membrane-attached particles. a, By TEM, HIV-1NL4-3 virions 
accumulating NCp15 present defects in nucleocapsid condensation while NCp9- and NCp7-
containing viruses show correct core condensation into electron-dense dark spot. Quantitation 
was done for close to 180 counted particles. b-c, The majority of membrane-attached HIV-1 
particles produced by latently infected ACH-2 cells are immature particles in presence of LPV 
(b), they contain an electron-dense dark spot indicative of nucleocapsid condensation without 
LPV (c). Quantitation was done for close to 200 particles for LPV-treated ACH2 cells and to 1000 
particles for non-treated ACH2 cells (d). 
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Figure 6 | Nucleocapsid condensation, quinary interactions and WSM transition of the 
nucleocapsid during HIV maturation. a, Weak-Strong-Moderate gluing properties of NC 
proteins with RNA (white) throughout virus maturation. p6 (orange)-NCp7 (green) contacts 
assemble NCp15 networks upon the RNA, blocking exposed residues engaged in NCp9 or NCp7 
: NA contacts. Cleavage of p6 unmasks the NCp9 domain, the NCp7-SP2 (yellow) domain 
engages NC:NA:NC and NA:NC:NA networks favouring strong RNA-gluing and RNP 
granulation. Cleavage of SP2 removes one “K/F/Q” NA binding patch (see Fig 2a), which reduces 
the quinary network between RNA and NCp7. b, Nucleocapsid WSM transition in the context of 
viral particle. (1) Virus particle at the plasma membrane bud from self-assembly of Gag and 
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GagPol on gRNA, with the NC domain as the RNA binder. The gRNA is shown in white within 
the layer of NC domains, assembled as bundles of six at the base of Gag hexamers. (2) The 
dimerization of GagPol self-activates PR (pink) and initiates maturation. (3) The SP1-NC site is 
cleaved, liberating the gRNA:NCp15 RNP, which in turns sequesters PR. (4) Rapid cleavage of 
NCp15 into NCp9, which liberates p6, unlocks the strong gluing properties of NCp9.  This quickly 
compacts the gRNA and favours viral budding. gRNA condensation allows internal 
reorganization of RT (red) and IN (gold), self-assembly of the conical capsid after separation of 
MA from CA-SP1 and maturation of CA-SP1 while NCp9 are matured to NCp7 in (5 & 6).  
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